Study of Phosphate Levels in Patients With Chronic Kidney Disease
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the ability of different doses of PA21 to lower
serum phosphate levels, in patients with chronic kidney disease on maintenance hemodialysis.